advanced basal cell carcinoma
Roche’s skin cancer drug passes mid-stage trial
March 22, 2011Research and Development Curis, Roche, advanced basal cell carcinoma, skin cancer, vismodegib
Roche’s skin cancer candidate vismodegib has met its primary endpoint in a phase II trial. The drug is being tested …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
